MUSTANG BIO, INC. — Investor Relations & Filings
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel cell and gene therapies. The company's primary focus is on translating medical breakthroughs into potential cures for difficult-to-treat cancers and rare genetic diseases. Its pipeline is centered on Chimeric Antigen Receptor (CAR) T-cell therapies, a form of immunotherapy. Mustang Bio's strategy involves in-licensing promising technologies from academic institutions and advancing them through clinical trials, supported by its in-house manufacturing capabilities to ensure the production and delivery of these advanced treatments.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q | 2021-11-12 | English | |
| OWNERSHIP DOCUMENT | 2021-11-08 | English | |
| OWNERSHIP DOCUMENT | 2021-10-21 | English | |
| FORM 8-K | 2021-09-28 | English | |
| OWNERSHIP DOCUMENT | 2021-09-24 | English | |
| OWNERSHIP DOCUMENT | 2021-09-24 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2021
15 filings
| |||||
| 12973278 | 10-Q | 2021-11-12 | English | ||
| 12973280 | OWNERSHIP DOCUMENT | 2021-11-08 | English | ||
| 12973279 | OWNERSHIP DOCUMENT | 2021-10-21 | English | ||
| 12973282 | FORM 8-K | 2021-09-28 | English | ||
| 12973281 | OWNERSHIP DOCUMENT | 2021-09-24 | English | ||
| 12973283 | OWNERSHIP DOCUMENT | 2021-09-24 | English | ||
| 12973284 | FORM 8-K | 2021-09-24 | English | ||
| 12973286 | 10-Q | 2021-08-16 | English | ||
| 12973287 | FORM 8-K | 2021-08-16 | English | ||
| 12973285 | OWNERSHIP DOCUMENT | 2021-08-05 | English | ||
| 12973288 | FORM S-8 | 2021-07-30 | English | ||
| 12973290 | FORM S-8 | 2021-07-30 | English | ||
| 12973289 | OWNERSHIP DOCUMENT | 2021-07-08 | English | ||
| 12973291 | OWNERSHIP DOCUMENT | 2021-07-08 | English | ||
| 12973293 | OWNERSHIP DOCUMENT | 2021-07-08 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
MUSTANG BIO, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35167/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35167 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35167 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35167 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35167}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for MUSTANG BIO, INC. (id: 35167)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.